Mukka Proteins Faces Financial Struggles Amid Significant Market Volatility and Declining Performance

Mukka Proteins, a microcap player in the FMCG sector, has experienced significant volatility, hitting a new 52-week low of Rs. 25.49 today. The stock has underperformed its sector by 4.39% and has seen a consecutive decline over the past two days, resulting in a total drop of 6.25%. Currently, Mukka Proteins is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a challenging market position.
In terms of financial performance, Mukka Proteins has reported a staggering 43.09% decline in returns over the past year, contrasting sharply with the Sensex's 1.50% gain. The company's net sales for the latest quarter fell by 32.1%, while profit before tax and profit after tax saw declines of 101.8% and 86.8%, respectively, compared to previous averages.

Institutional investor participation has also waned, with a 0.65% decrease in stake over the last quarter, now holding just 3.96% of the company. Despite a healthy long-term growth rate in operating profit of 50.86%, Mukka Proteins faces challenges with a high Debt to EBITDA ratio of 4.36 times and a low return on capital employed of 9.48%.